Interviews

In this clip, Ben Urick, PharmD, PhD, a research assistant professor at the University of North Carolina Eshelman School of Pharmacy, shared his advice for student pharmacists.

Achilles Alon, PharmD, RPh, director of Specialty Pharmacy, co-owner of ACE-Rx Specialty Pharmacy, discusses the concerns regarding DIR fees and the impact it may have.

In this clip, Jim Flood, the chair of Crowell & Moring's Government Affairs Group, discusses why it's important for pharmacists to speak to political candidates.

In this clip, Jim Flood, the chair of Crowell & Moring's Government Affairs Group, discusses several public policy issues that pharmacists should follow.

In this clip, Scott Douglas, a senior policy director at Crowell & Moring, discusses what pharmacists can do to advocate for the profession in the political arena.

In this clip, Scott Douglas, a senior policy director at Crowell & Moring, discusses why provider status legislation has yet to be passed.

In this clip, Scott Douglas, a senior policy director at Crowell & Moring, discusses the current state of provider status legislation.

Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses the growth of pharmacy accreditation offerings.

At the National Community Oncology Dispensing Association's (NCODA) 2018 Spring Summit, Julianne Orr, PharmD, from Indiana University Health Simon Cancer Center, discusses the pharmacist's role in managing adherence to oral treatment regimens for patients with cancer.

Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses the growth of pharmacy accreditation offerings.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data aggregators work with pharmacies and manufacturers to boost patient support services.

Luis Torres, MBA, vice president, Managed Care, BioPlus Specialty Pharmacy, discusses the importance of co-pay assistance programs for costly specialty drugs.

Christopher W. Kennedy, MSM, Chief Operating Officer, Heritage Biologics, discusses how data can translate to improvements in patient care.

At the 2018 National Community Oncology Dispensing Association (NCODA) Spring Summit, Ali McBride, PharmD, MS, BCPS, BCOP, explains what strategies can help ensure patients are adherent to oral chemotherapy regimens.

At the 2018 National Community Oncology Dispensing Association (NCODA) Spring Summit, Ray Bailey, BPharm, RPh, Pharmacy Director at Florida Cancer Speciality, discusses interventions aimed at reducing the waste and cost of expensive oral chemotherapy treatments.

Brandon Newman, PharmD, CSP, Program Director, Vanderbilt Specialty Pharmacy, speaks about how specialty pharmacies have to adjust their operations to meet the needs of their patients.

At the 2018 National Community Oncology Dispensing Association (NCODA) Spring Summit, Howard Cohen, RPh, MS, FASHP, from Smilow Cancer Hospital, Yale-New Haven Health, discusses how information technology can be utilized to improve medication adherence on patients with cancer.

At the 2018 National Community Oncology Dispensing Association (NCODA) Spring Summit, Ray Bailey, BPharm, RPh, Pharmacists Director at Florida Cancer Specialists, discusses important considerations for managing oral chemotherapy care plans and improving adherence in patients.

Christopher W. Kennedy, MSM, Chief Operating Officer, Heritage Biologics, speaks about the positive effects telehealth can have on specialty pharmacy patients.

Ron Lanton III, Esq, President, True North Political Solutions, makes predictions about how dealings with biosimilars may change in 2018.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses the data customers should be asking for from a specialty pharmacy.

At the 2018 National Community Oncology Dispensing Association (NCODA) Spring Summit, Julianne Orr, PharmD, from the Indiana University Health Simon Cancer Center, discusses how pharmacists can help patients who are transitioning from an infusion product to an oral chemotherapy.

Ron Lanton III, Esq, President, True North Political Solutions, discusses how drug manufacturers have responded to the emergence of biosimilars thus far.

Christopher W. Kennedy, MSM, Chief Operating Officer, Heritage Biologics, discusses how specialty pharmacies can implement value-based reimbursement.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, talks about the potential merits of outcomes-based contracting for drugs that treat rare diseases.

Matt Gillin, Chief Executive Officer, Relay Network, speaks about how smartphones are crucial to the patient journey.

In this clip, Angela Yao, a PharmD candidate at the Rutgers University Ernest Mario School of Pharmacy, discusses the first of three qualities that she believes are essential to pharmacy students: mentorship.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, shares complications in treating patients with Crohn's disease.

Kyle Truitt, Co-Founder, Turning Point, LLC, speaks about how pharmaceutical manufacturers can benefit from the launch of the High-Performing Specialty Pharmacy Association.

Ron Lanton III, Esq., President, True North Political Solutions, speaks about proposed legislation that could bolster the emergence of biosimilars.